Latest Treatment on Prostate Cancer

Latest Treatment on Prostate Cancer - Prostate cancer is the most common cancer among men, with 10,000 deaths among 35,000 cases each year, affecting a third of men older than 50 years.

Therapies are invasive and require overnight stays in hospital, with multiple visits for further treatment.

Also have important and long-term side affects that many men put off.

However, new research shows that the intensity of the ultrasound therapy match the cure rate of 92 per cent of treatments - but considerably reduced side effects. - Latest Treatment -

pioneering treatment more successfull than surgery

The technique is also much simpler, involving a visit outside, patients are discharged from hospital after hours.

Moreover, those who undergo ultrasound can regain a normal life in just one or two weeks compared to a maximum of six months for other treatments.

The National Institute for Health and Clinical Excellence, the NHS rationing body, has already reviewed the test results "questionable", has promised to consider new evidence that the assessment of technology for use in health services.

It is currently maintained in clinical trials, but the results have been described as "excellent news" for cancer charities.

"This technique requires a careful assessment to ensure that it can produce the same results as early treatment of prostate cancer," said Professor Peter Johnson, medical director of Cancer Research UK.

"If treatment can be shown to have fewer side effects, which is great news, but more research is needed to prove it."

The ministers intend to introduce a national screening for prostate cancer, after the largest study of its kind suggested that this could save lives.

treatments for prostate cancer

However, experts have warned that the risks associated with surgery to remove some of the slow-growing tumors, which include incontinence in May, outweigh the risks of the disease for many men.

If you are early treatments such as radiotherapy and surgery can reduce the spread of cancer, but side effects severe damage to the quality of life.

In men treated with surgery or radiotherapy, up to 20 percent suffer from incontinence and impotence have half.

Radiation can also cause other side effects to one in five patients, including pain and bleeding.

The new technique, known as High Intensity Focused Ultrasound direction (HIFU) is a powerful Soundwave area of about one tenth of an inch wide. Boiled effectively cancer cells to death, kill the tumor, and it is much less invasive.

At the trial of 172 men conducted by the University College Hospital and the private Princess Grace Hospital in London, less than one percent of incontinence, none had intestinal problems and about 35 per cent had the 'powerlessness.

All men in the study, published in the British Journal of Cancer, the cases were days, almost all hospitals to an average of five hours.

Dr. Ahmed Hashim, who led the trial, said preliminary results suggest the absence of side effects and shorter hospital stay "clear benefits for men with prostate cancer."

He hoped that the Treaty of Nice, the rationing body, which allows to consider seriously the possibility to extend to the entire NHS.

Latest Treatment

Professor Karol Sikora, an expert in treating cancer, said: "It is very encouraging that new approaches for prostate cancer are needed. I think anything that can reduce the side effects is a good thing. "

John Neate, chief executive of the Prostate Cancer Charity, said it was "promising" and could be a "third way" in the treatment of the disease, although more research is needed.

"Because HIFU is a new technology, the data do not exist, and longer-term trials are needed, but these results are promising," he said.

A spokesperson for NICE said: "We will examine each piece of new evidence to see if it has an impact on management." This news is about "Latest Treatment on Prostate Cancer"

read more>>

Quality of life in younger vs. older men after radical prostatectomy

A research team has studied the impact of age on survival after radical prostatectomy by comparing outcomes between men of < 70 (n = 526) and ? 70 years of age (n = 100) in a single prospective series.

According to researchers report, there were no differences between the two groups of patients: the 10-year PSA-free survival for young and old patients was 51.8 and 57.4 percent; the 10-year disease-specific survival was 92.3 and 97.6 percent; the 10-year metastasis-free survival was 86.9 and 89.7 percent; and the 10-year overall survival was 78.1 and 71.2 percent (P = 0.565).

The researchers conclude that, for a well-selected, healthy, elderly population, survival outcomes are no worse than those seen in younger patients.

read more>>

A new drug against nauseas of the chemotherapy

A new drug against nauseas of the chemotherapy -  the antivomiting symptoms improve when adding casopitant to both habitual The vomits and nauseas continue being the main indirect effect of the treatments against the cancer. “Quimio”, the combined x-ray and its uses bring about these annoying symptoms in the patients although medecines exist to fight them. The problem is that their effects usually do not last more of a day. A new clinical test has demonstrated the effectiveness of a drug that, addition to the habitual regime of two antivomiting ones, reduces nauseas as of the first 24 hours.

The study, sponsored by the pharmaceutics GlaxoSmithKline, was realised in 77 centers of 22 countries with patients who had a solid tumor (ovary, bladder, cervix, of lung of small cells…) that they were going to receive chemotherapy with cisplatino. This agent, who has demonstrated to be very useful in the treatment of these pathologies, is also one of the drugs that more nauseas and vomits cause.

The 810 people who took part in the test divided between groups. All of them received the habitual treatment to avoid these uncomfortable symptoms (dexametasona and ondansetrón) and placebo, in the case of group control. In the other two collections a dose to casopitant, an antagonist of receiver NK1 was added in addition. In a case it was administered by oral route and in other, intravenous.

Generally, the patients dealt with this antivomiting one were more contentments with the therapy and thought most frequently that the vomits had not interfered in their daily life. Like negative note, they were more prone to undergo adverse effects and to that these were serious. However, one is habitual reactions to the chemotherapy (neutropenia, dehydration, etc.) and not directly related to casopitant.

A high percentage of the patients who receive quimio or x-ray, single or combined, has nauseas and vomits. The habitual thing is that these appear up to five days after each cycle, affecting to the quality of life of the patient. The advances in the field of the farmacoterapia have allowed the discovery of some medecines able to reduce these symptoms. But antivomiting the habitual ones usually do not have effect once passed the first 24 hours.

At the moment, casopitant seems to be useful to avoid delayed nauseas. However, “more studies will be necessary to demonstrate their effectiveness in other patients, like whom] has nauseas brought about by a x-ray [… or those deal with other quimioterapéuticos agents”, point the authors.

read more>>

UNDER-AGE PREGNANCY AND ADVANCED MATERNAL AGE

Under-age pregnancy refers to pregnancy in girls under the age of consent (16 years in the UK). The term ‘elderly’ is applied to parturients over the age of 35. The UK has one of the highest teenage pregnancy rates in Europe, whereas the incidence of older women becoming pregnant is increasing in the developed world as a result of both maternal choice and infertility treatment.

Problems/special considerations


Under-age pregnancy

Those girls who are under-age when they present in pregnancy can be placed in the following groups:

• Those who have had normal antenatal care and have the full support of their family. This group usually have a parent available to give consent on behalf of the minor if that is felt appropriate, e.g. for epidural analgesia or for anaesthesia.
• Concealed pregnancy. This group may pose a problem with consent. Many will have had little or no antenatal care and may present to the hospital for the first time when they are in labour. Many present in advanced labour or to the Accident and Emergency Department with a life-threatening condition such as eclampsia, and there may not be time to find a parent or guardian before instituting treatment. Overall, this is an ‘at-risk’ group who often need consid¬erable support, including epidural analgesia.

Hypertension, anaemia, premature labour and low birth weight are all more common in under-age mothers.

Advanced maternal age

Miscarriage, fetal chromosomal abnormalities, multiple pregnancy, hypertension, diabetes, instrumental delivery, neonatal mortality and postpartum haemorrhage are more common in elderly mothers, who feature disproportionately in the Reports on Confidential Enquiries into Maternal Deaths.

read more>>

Obama is committed to reforming the health system and fight against cancer

The U.S. president Barack Obama pledged Tuesday to seek treatment to cure cancer "in our time" and reform "deeply" the U.S. health care system, in a solemn speech before Congress.

Barack Obama said the plan to revive the economy would launch "a new effort to defeat a disease that affects almost every American, seeking a remedy to cure cancer in our time."

The President said he would bring "the greatest means ever given to preventive care, because he is one of the best ways to keep people healthy and control costs of health, at - he added, during his first speech to both houses of Congress since his inauguration on January 20.

Mr. Obama also called for "a response to the exorbitant costs of health" which are the increasing costs "soon" in the U.S. budget.

"Over the past eight years, the cost of health insurance has risen four times faster than wages. And during these years is a million Americans who have lost their health coverage," he explained.

The candidate Obama had promised during the presidential campaign to provide health coverage to 46 million Americans who would not.

"Given this situation, we can no longer afford to wait more to reform the health system," he said. "Already we have made over these last thirty days that what was done during the last decade," he said, referring to the law expanding the health insurance system for children.

He said that the plan to revive the economy 787 billion issued last week would upgrade the current devices and thus eventually reduce costs.

The draft 2010 budget, he will present Thursday, includes a historic commitment to reform deeply the health system, "said Obama.

"It's an effort that we must do if we want to reduce our deficit in the years to come," he said.

"There will be many different opinions and ideas on how to carry out this reform, which is why I call workers, doctors, health insurance, Democrats and Republicans to start working on this issue next week , "he said.

Barack Obama announced Monday the next week held a summit on reforming health insurance. "It will be difficult, he acknowledged. But I also know that almost a century after that (former U.S. President) Teddy Roosevelt has been asked to do this reform, the cost of our health care system burdened our economy for too long.

"Also should not there be no doubt: the reform of the health system can not wait, should not expect, and will not wait one more year," promised Mr. Obama.

read more>>

Lung cancer revealing social inequalities

Tobacco account for slightly more than half of these inequalities. Still other risk factors could be involved, starting with exposure to toxic environmental.

In association with other European researchers, Gwenn Menvielle of Unit 687 INSERM (Villejuif) worked on the large cohort - 390 men and 000 women from 9 countries - which has served as the EPIC (European Prospective Investigation into Cancer and Nutrition). With an incidence of 71.8 cases per 100 000 among men, lung cancer is the leading cause of male mortality. And the third for women.

"The rate (...) are relatively uniform in Europe among men, but two times higher among women in northern Europe than in the South," says INSERM. The authors have shown that for both sexes, the risk decreases as the level of education. Except in Spain, Greece and Italy, where "the rate of occurrence of lung cancer are highest among women the most socially advantaged."

The risk is thus 3.6 times higher for men and 2.4 times among women in disadvantaged compared to the more affluent population. However, tobacco consumption is only part of the inequalities. It is therefore necessary to identify other risk factors, "says Gwenn Menvielle. The latter states, however, that "quitting smoking would prevent a considerable number of these lung cancers.

read more>>

Over 40% of breast cancer and colon cancer preventable nutrition and exercise

Over 40% of cancers of the colon and breast could be prevented in developed countries through a balanced diet, regular physical activity and body weight control, according to a report released Thursday.

According to the report, entitled "Policies and actions for the prevention of cancer, 43% of colon cancers and 42% of breast cancers could be prevented in developed countries.

More generally, "about 1 / 3 of the most common cancers in developed countries could be prevented" and "1 / 4 in developing countries."

These figures do not include cancers attributable to smoking, representing about 1 / 3 of cancer.

The study was conducted by the Global Fund for Research on Cancer, a French charity, and the American Institute for Cancer Research, another association, which analyzed the impact of 12 types of cancer in four countries, USA, Great Britain, Brazil and China.

Commenting on the report, Professor Michael Marmot, chair of the panel, stressed that "in the prevention of cancer, all members of society have a role to play", heads of state to individuals.

Fifty recommendations, developed by 23 experts, are made to ban the sale of snacks too sweet or too fatty in dispensers in the school which is already the case in France-, differentiate in the news the public reports and news articles, to cease advertising and promotion for food or beverages are harmful to children, developing bicycle and pedestrian area ...

12 million new cancer cases were diagnosed in 2008 in the world and there were 7.6 million deaths.

read more>>

Fluogel: replacements ... but more expensive

The 11 000 patients are presented with two alternatives. But unlike Fluogel, they are not supported by the Health Insurance ...

Now a year Fluogel (90ml) is unavailable, due to a disruption in the supply of an active ingredient. And "to date, we can not decide on a date of delivery available," said Thierry Souchon, the pharmacist responsible for the firm Procter & Gamble, which markets the drug.

Two alternatives are proposed by industrial Fluodontyl (75ml) and Fluocaril bifluoré 2000 (250ml). The terms of prescription of the latter have recently been expanded. Previously reserved for dentists and oral and maxillofacial surgeons, this treatment should be available in pharmacies in town.

The tariffs, however, raise questions: Fluocaril bifluoré 2000 should be marketed at a price of 18 to 20 euros per tube, according to the pharmacies. ... Cost is 4 times higher than Fluogel (4.75 euros). In a letter to pharmacists, pharmacy, Thierry Souchon said that his company "(was) a request supported by Social Security Fluocaril bifluoré 2000. Meanwhile, the price is high ... As for patients who want to see on Fluodontyl, they must pay between 5 and 11 euros, according to pharmacists contacted.

read more>>